Literature DB >> 4744597

Combination chemotherapy in advanced and recurrent Hodgkin's disease.

T J McElwain, P F Wrigley, A Hunter, D Crowther, J S Malpas, M J Peckham, D W Smithers, G H Fairley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4744597

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  7 in total

1.  Management of Hodgkin's disease in childhood.

Authors:  I E Smith; T J McElwain
Journal:  Arch Dis Child       Date:  1977-09       Impact factor: 3.791

2.  Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.

Authors:  J A Green; A A Dawson; L F Fell; S Murray
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

3.  [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

Authors:  F J Tigges; E Hiller; R M Schmülling; H D Waller; K Wilms
Journal:  Blut       Date:  1978-08-15

4.  A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.

Authors:  T J McElwain; J Toy; E Smith; M J Peckham; D E Austin
Journal:  Br J Cancer       Date:  1977-08       Impact factor: 7.640

5.  Hodgkin's disease in children.

Authors:  I E Smith; M J Peckham; T J McElwain; J C Gazet; D E Austin
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

6.  Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.

Authors:  P J Dady; T J McElwain; D E Austin; A Barrett; M J Peckham
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

7.  Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

Authors:  S B Kaye; C A Juttner; I E Smith; A Barrett; D E Austin; M J Peckham; T J McElwain
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.